Prophase Labs Stock Price on December 27, 2024
| PRPH Stock | USD 0.64 0.01 1.59% |
Below is the normalized historical share price chart for ProPhase Labs extending back to April 04, 1994. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ProPhase Labs stands at 0.64, as last reported on the 29th of December, with the highest price reaching 0.67 and the lowest price hitting 0.62 during the day.
If you're considering investing in ProPhase Stock, it is important to understand the factors that can impact its price. ProPhase Labs maintains Sharpe Ratio (i.e., Efficiency) of -0.23, which implies the firm had a -0.23% return per unit of risk over the last 3 months. ProPhase Labs exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ProPhase Labs' Coefficient Of Variation of (504.80), risk adjusted performance of (0.15), and Variance of 55.35 to confirm the risk estimate we provide.
ProPhase Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of January 1997 | 200 Day MA 3.3055 | 50 Day MA 1.2006 | Beta (0.1) |
ProPhase |
Sharpe Ratio = -0.2285
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PRPH |
Estimated Market Risk
| 7.45 actual daily | 66 66% of assets are less volatile |
Expected Return
| -1.7 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ProPhase Labs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ProPhase Labs by adding ProPhase Labs to a well-diversified portfolio.
Price Book 0.3989 | Enterprise Value Ebitda 2.4498 | Price Sales 0.8462 | Shares Float 15.7 M | Wall Street Target Price 18.5 |
Related Headline
ESSA Pharma Headline on 27th of December 2024
ESSA Pharma Stock Price Passes Below 50-Day Moving Average T... by thelincolnianonline.com
ESSA Pharma Inc. s stock price crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of 2.66 and traded as low as 1.60. ESSA Pharma shares last traded at 1.61, with a volume of 40,449 shares traded. Analyst Upgrades and Downgrades
ProPhase Labs Valuation on December 27, 2024
It is possible to determine the worth of ProPhase Labs on a given historical date. On December 27, 2024 ProPhase was worth 0.66 at the beginning of the trading date compared to the closed value of 0.64. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ProPhase Labs stock. Still, in general, we apply an absolute valuation method to find ProPhase Labs' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ProPhase Labs where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ProPhase Labs' related companies.
| Open | High | Low | Close | Volume | |
| 0.63 | 0.64 | 0.62 | 0.63 | 145,688 | |
12/27/2024 | 0.66 | 0.67 | 0.62 | 0.64 | 245,212 |
| 0.66 | 0.67 | 0.62 | 0.64 | 0.00 |
| Backtest ProPhase Labs | | | ProPhase Labs History | | | ProPhase Labs Valuation | Previous | Next |
ProPhase Labs Trading Date Momentum on December 27, 2024
| On December 29 2024 ProPhase Labs was traded for 0.64 at the closing time. The top price for the day was 0.67 and the lowest listed price was 0.62 . There was no trading activity during the period 0.0. Lack of trading volume on December 29, 2024 did not cause price change. The trading delta at closing time against the current closing price is 3.13% . |
ProPhase Labs Fundamentals Correlations and Trends
By evaluating ProPhase Labs' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ProPhase Labs' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ProPhase financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ProPhase Labs Stock history
ProPhase Labs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ProPhase is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ProPhase Labs will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ProPhase Labs stock prices may prove useful in developing a viable investing in ProPhase Labs
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter consumer healthcare products and dietary supplements in the United States. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York. Prophase Labs operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 129 people.
ProPhase Labs Quarterly Net Working Capital |
|
ProPhase Labs Stock Technical Analysis
ProPhase Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ProPhase Labs Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
ProPhase Labs cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ProPhase Labs December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how ProPhase Labs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ProPhase Labs shares will generate the highest return on investment. By undertsting and applying ProPhase Labs stock market strength indicators, traders can identify ProPhase Labs entry and exit signals to maximize returns
ProPhase Labs Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ProPhase Labs' price direction in advance. Along with the technical and fundamental analysis of ProPhase Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ProPhase to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (1.45) | |||
| Total Risk Alpha | (1.69) | |||
| Treynor Ratio | 0.9665 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for ProPhase Stock analysis
When running ProPhase Labs' price analysis, check to measure ProPhase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProPhase Labs is operating at the current time. Most of ProPhase Labs' value examination focuses on studying past and present price action to predict the probability of ProPhase Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProPhase Labs' price. Additionally, you may evaluate how the addition of ProPhase Labs to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |